MoonLake Immunotherapeutics (MLTX) Current Reports & Earnings Releases
Upcoming
- 2026-11-04 Earnings Release Estimated
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-10 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-07-15 | 8-K | Other Events | SEC |
| 2026-06-25 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2026-06-22 | 8-K | Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2026-06-09 | 8-K | Officer / Director Changes, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2026-06-01 | 8-K | Material Agreement | SEC |
| 2026-05-11 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-02-23 | 8-K | Material Agreement, Results of Operations, Direct Financial Obligation, Officer / Director Changes, Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2026-01-08 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-11-05 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2025-11-05 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-09-29 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-08-05 | 8-K | Results of Operations | SEC |
| 2025-06-06 | 8-K | Shareholder Vote Results | SEC |
| 2025-05-12 | 8-K | Results of Operations | SEC |
| 2025-04-29 | 8-K | Reg FD Disclosure | SEC |
| 2025-04-03 | 8-K | Material Agreement, Direct Financial Obligation, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-02-26 | 8-K | Results of Operations | SEC |
| 2024-12-18 | 8-K | Officer / Director Changes | SEC |
| 2024-11-07 | 8-K | Results of Operations | SEC |
| 2024-09-11 | 8-K | Reg FD Disclosure | SEC |
| 2024-08-07 | 8-K | Results of Operations | SEC |
| 2024-06-10 | 8-K | Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2024-06-06 | 8-K | Shareholder Vote Results | SEC |
| 2024-05-07 | 8-K | Results of Operations | SEC |
| 2024-03-11 | 8-K | Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2024-02-29 | 8-K | Results of Operations | SEC |
| 2024-02-26 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.